Fredag 25 Juli | 06:30:33 Europe / Stockholm

Prenumeration

2025-07-22 08:20:00

Redeye updates its estimates and fair value range following Arise’s Q2 report. We think that the Q2 report was underlying largely in line with our estimates. Also, the late-stage project portfolio continued to grow, which we think positions Arise for the harvesting period in H2, which should allow the company to reach its first set of financial targets for 2025.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/